BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 14569849)

  • 1. Toward a breast cancer vaccine: work in progress.
    Emens LA; Jaffee EM
    Oncology (Williston Park); 2003 Sep; 17(9):1200-11; discussion 1214, 1217-8. PubMed ID: 14569849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a therapeutic breast cancer vaccine: the next steps.
    Emens LA
    Expert Rev Vaccines; 2005 Dec; 4(6):831-41. PubMed ID: 16372879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity.
    Emens LA; Reilly RT; Jaffee EM
    Endocr Relat Cancer; 2005 Mar; 12(1):1-17. PubMed ID: 15788636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-HER2 vaccines: The HER2 immunotargeting future?].
    Ladjemi MZ; Jacot W; Pèlegrin A; Navarro-Teulon I
    Pathol Biol (Paris); 2011 Jun; 59(3):173-82. PubMed ID: 19481373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunizing against breast cancer: a new swing for an old sword.
    Curigliano G; Locatelli M; Fumagalli L; Goldhirsch A
    Breast; 2009 Oct; 18 Suppl 3():S51-4. PubMed ID: 19914543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium.
    Curigliano G; Criscitiello C; Esposito A; Fumagalli L; Gelao L; Locatelli M; Minchella I; Goldhirsch A
    Breast; 2013 Aug; 22 Suppl 2():S96-9. PubMed ID: 24074802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in Vaccine Therapies for Breast Cancer.
    Li X; Bu X
    Adv Exp Med Biol; 2017; 1026():315-330. PubMed ID: 29282691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of breast cancer.
    Wright SE
    Expert Opin Biol Ther; 2012 Apr; 12(4):479-90. PubMed ID: 22413825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunotherapy: a treatment for the masses.
    Blattman JN; Greenberg PD
    Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
    Baxevanis CN; Perez SA; Papamichail M
    Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunology and breast cancer: therapeutic cancer vaccines.
    Curigliano G; Rescigno M; Goldhirsch A
    Breast; 2007 Dec; 16 Suppl 2():S20-6. PubMed ID: 17706425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-idiotype vaccines for immunotherapy.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic approaches to breast cancer treatment.
    Sabel MS; Nehs MA
    Surg Oncol Clin N Am; 2005 Jan; 14(1):1-31, v. PubMed ID: 15541997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer immunotherapy.
    Zhou J; Zhong Y
    Cell Mol Immunol; 2004 Aug; 1(4):247-55. PubMed ID: 16225767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice.
    Wang L; Xie Y; Ahmed KA; Ahmed S; Sami A; Chibbar R; Xu Q; Kane SE; Hao S; Mulligan SJ; Xiang J
    Breast Cancer Res Treat; 2013 Jul; 140(2):273-84. PubMed ID: 23881522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current immunotherapeutic strategies in breast cancer.
    Carson WE; Liang MI
    Surg Oncol Clin N Am; 2007 Oct; 16(4):841-60, ix. PubMed ID: 18022548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer immunotherapy: monoclonal antibodies and peptide-based vaccines.
    Mohit E; Hashemi A; Allahyari M
    Expert Rev Clin Immunol; 2014 Jul; 10(7):927-61. PubMed ID: 24867051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC1-based recombinant Bacillus Calmette-Guerin vaccines as candidates for breast cancer immunotherapy.
    Yuan S; Shi C; Liu L; Han W
    Expert Opin Biol Ther; 2010 Jul; 10(7):1037-48. PubMed ID: 20420512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.